Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neuroblastoma × XK 469 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Congenital Abnormalities 1 Blast Crisis 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 29 Filgrastim 16 Irinotecan 14 Topotecan 13 Temozolomide 12 Melphalan 11 Granulocyte Colony-Stimulating Factor 11 fludarabine 10 Vincristine 10 Peripheral Blood Stem Cell Transplantation 10 Etoposide 9 Isotretinoin 8 Busulfan 8 dinutuximab 7 3-Iodobenzylguanidine 7 humanized 3F8 anti-GD2 monoclonal antibody 6 fludarabine phosphate 6 Interleukin-2 6 Doxorubicin 6 Carboplatin 6 sargramostim 5 aldesleukin 5 Vorinostat 5 Stem Cell Transplantation 5 Cisplatin 5 etoposide phosphate 4 Zoledronic Acid 4 Ipilimumab 4 ribociclib 3 Specimen Handling 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00028522 2013-12-16

R(+)XK469 in Treating Patients With Advanced Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡